Genmab A (GMAB) Cash from Investing Activities (2020 - 2026)

Genmab A (GMAB) has reported Cash from Investing Activities for 6 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Investing Activities rose 111.76% year-over-year to $2.0 million; the trailing twelve-month figure through Jun 2026 stood at -$95.0 million (up 96.8% YoY), and the FY2025 full-year result was -$5.6 billion, down 289.98% from the prior year.
• Cash from Investing Activities climbed to $2.0 million in Q2 2026 per GMAB's latest filing, from -$9.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $2.0 million in Q2 2026 and bottomed at -$1.5 billion in Q2 2024.
• Historically, Cash from Investing Activities has averaged -$448.4 million across 4 years, with a median of -$71.0 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Cash from Investing Activities plunged 1515.38% in 2024, then jumped 111.76% in 2026.
• Over 4 years, Cash from Investing Activities stood at -$185.0 million in 2023, then slumped by 682.16% to -$1.4 billion in 2024, then soared by 95.09% to -$71.0 million in 2025, then soared by 102.82% to $2.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $2.0 million, -$9.0 million, and -$71.0 million for Q2 2026, Q1 2026, and Q3 2025 respectively.